COVID-19 VACCINES USE EXPERIMENTAL TECHNOLOGY
Until now all vaccines have been developed using an actual inactivated or attenuated version of the virus or bacterium for which the vaccine has been developed. Currently three different COVID-19 vaccines have been authorized for emergency use in the United States and are being administered to the public. Two of these vaccines (developed by Pfizer and Moderna) do not use any actual virus or viral material in their production. Instead these vaccines use what is called mRNA technology, a new type of technology that has never before been used to vaccinate humans for infectious disease. mRNA is short for messenger ribonucleic acid. mRNA is what carries genetic instructions from DNA to the ribosome of cells. This is where proteins are created that serve all manner of biological function.
These new COVID-19 vaccines use a synthetically created mRNA strand that, when injected into your body, is transported into the cells delivering a genetic sequence that instructs the cells to create what is called a spike protein. This spike protein resembles the spike protein that resides on the surface of the COVID-19 virus. As your cells produce this similar protein, your body identifies it as foreign and consequently elicits an immune response. If you are exposed to the COVID-19 virus after having mounted an immune response to this vaccine, in theory your body will then have the antibodies and immunologic memory to deal with it.
Many health professionals and scientists are raising valid concerns over the potential dangers, as well as risk to benefit ratio, of this new and experimental vaccine. Among these concerns are genetic interference via reverse transcription, development of autoantibodies leading to autoimmune disorders and fertility issues, anaphylactic reactions to highly allergenic nano particulate ingredients that haven't been used in vaccinations before, and enhancement of severity of the disease from pathogenic priming - the latter of which being one reason that prior safe and successful development of a vaccine for this family of viruses has evaded researchers. The short duration of clinical trials, skipping of animal trials, use of novel technology, and most importantly the alarming number of deaths and adverse reactions already reported, yield to these concerns.
These new COVID-19 vaccines use a synthetically created mRNA strand that, when injected into your body, is transported into the cells delivering a genetic sequence that instructs the cells to create what is called a spike protein. This spike protein resembles the spike protein that resides on the surface of the COVID-19 virus. As your cells produce this similar protein, your body identifies it as foreign and consequently elicits an immune response. If you are exposed to the COVID-19 virus after having mounted an immune response to this vaccine, in theory your body will then have the antibodies and immunologic memory to deal with it.
Many health professionals and scientists are raising valid concerns over the potential dangers, as well as risk to benefit ratio, of this new and experimental vaccine. Among these concerns are genetic interference via reverse transcription, development of autoantibodies leading to autoimmune disorders and fertility issues, anaphylactic reactions to highly allergenic nano particulate ingredients that haven't been used in vaccinations before, and enhancement of severity of the disease from pathogenic priming - the latter of which being one reason that prior safe and successful development of a vaccine for this family of viruses has evaded researchers. The short duration of clinical trials, skipping of animal trials, use of novel technology, and most importantly the alarming number of deaths and adverse reactions already reported, yield to these concerns.
SOURCES
Dr. James Lyons Weiler on pathogenic priming, autoimmunity and concerns over the COVID-19 vaccine:
Will and RNA Vaccine Permanently Alter My DNA?
Concerns over biological plausibility of reverse transcription
Anaphylaxis Following mRNA Covid-19 Vaccine Receipt
CDC report on anaphylactic reaction risk to COVID-19 vaccine ingredients
COVID-19 Vaccine Adverse Events Data
Current U.S. death and adverse events reports to the Vaccine Adverse Event Reporting System
Suspicions Grow That Nanoparticles in Pfizer's Covid-19 Vaccine Trigger Rare Allergic Reactions
Article and information on anaphylactic allergic reaction to COVID-19 vaccine ingredients
Concerns over biological plausibility of reverse transcription
Anaphylaxis Following mRNA Covid-19 Vaccine Receipt
CDC report on anaphylactic reaction risk to COVID-19 vaccine ingredients
COVID-19 Vaccine Adverse Events Data
Current U.S. death and adverse events reports to the Vaccine Adverse Event Reporting System
Suspicions Grow That Nanoparticles in Pfizer's Covid-19 Vaccine Trigger Rare Allergic Reactions
Article and information on anaphylactic allergic reaction to COVID-19 vaccine ingredients